Results 41 to 50 of about 3,765 (219)
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare primary cutaneous lymphoma characterized by infiltration of the subcutaneous tissue by neoplastic cytotoxic T cells mimicking panniculitis.
Weeratian Tawanwongsri +1 more
doaj +1 more source
Erythema nodosum induced by oral isotretinoin in a patient with condylomata acuminata [PDF]
Erythema nodosum (EN) is a form of septal panniculitis, which is believed to represent a delayed hypersensitivity reaction activated by infectious agents, drugs, granulomatous and autoimmune diseases, pregnancy, and malignancies.
Badavanis, George +4 more
core
Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek +3 more
wiley +1 more source
Utility of CD123 immunohistochemistry in differentiating lupus erythematosus from cutaneous T cell lymphoma [PDF]
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149293/1/his13817_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/149293/2/his13817 ...
Chan, May P +4 more
core +1 more source
Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee +9 more
wiley +1 more source
Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%–3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti‐TNF‐α therapies. Clinically, it is characterised by tender,
Cristina Grechin +4 more
doaj +1 more source
Histoplasma panniculitis in a patient with systemic lupus erythematosus [PDF]
: Histoplasmosis usually presents primarily as lung infection. Occasionally, mainly in immunocompromised hosts, it can spread and cause systemic manifestations.
Luis Rodrigo Flores-Bozo +2 more
doaj +2 more sources
International Expert Consensus on Knowledge Gaps in Care for Dermatologic Disorders in Skin of Color
State‐of‐the‐art knowledge gaps in dermatological disorders, photoprotection and procedural dermatology in individuals with skin of color (SOC). ABSTRACT Patients with skin of color (SOC) face unique dermatologic challenges that are often underrepresented in research and in dermatological education, creating critical gaps in care.
Henry W. Lim +8 more
wiley +1 more source
Skin lesions in systemic lupus erythematosus. Part 2: clinical and histological features
Skin lesions in systemic lupus erythematosus (SLE) are not just a cosmetic defect, accompanied by a deterioration in the quality of life and psychological discomfort, but, possibly, the first sign of a systemic course of disease. Systemic involvement can
A. A. Shumilova +2 more
doaj +1 more source
Hydrogel‐forming microneedle patches are developed using shape‐preserving PVA‐PVP hydrogels, with and without chitosan, for minimally invasive transdermal protein biomarker sampling. The optimised patches enable efficient interstitial fluid uptake and proteomic analysis, while minimising interference.
Achmad Himawan +12 more
wiley +1 more source

